inclusion criteria: 1. adults who agree to participate and sign informed consent. 2. suspected case, according to the operational definition (conave).\* 3. in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).\*\* 4. the time of acute respiratory symptoms should be no longer than 72h. 5. negative to the rapid test for influenza a/b. 6. live in an urban area with easy access for visits. * person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain \*\*sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.

inclusion criteria: 1. adults who agree to participate and sign informed consent. 2. suspected case, according to the operational definition (conave).\* 3. in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).\*\* 4. the time of acute respiratory symptoms should be no longer than 72h. 5. negative to the rapid test for influenza a/b. 6. live in an urban area with easy access for visits. * person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain \*\*sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.

inclusion criteria: adults who agree to participate and sign informed consent. suspected case, according to the operational definition (conave).* in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).** the time of acute respiratory symptoms should be no longer than 72h. negative to the rapid test for influenza a/b. live in an urban area with easy access for visits. person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain **sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.

inclusion criteria: adults who agree to participate and sign informed consent. suspected case, according to the operational definition (conave).* in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).** the time of acute respiratory symptoms should be no longer than 72h. negative to the rapid test for influenza a/b. live in an urban area with easy access for visits. person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain **sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.

inclusion criteria: 1. adults who agree to participate and sign informed consent. 2. suspected case, according to the operational definition (conave).* 3. in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).** 4. the time of acute respiratory symptoms should be no longer than 72h. 5. negative to the rapid test for influenza a/b. 6. live in an urban area with easy access for visits. - person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain **sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.

inclusion criteria: 1. adults who agree to participate and sign informed consent. 2. suspected case, according to the operational definition (conave).* 3. in the case of confirmed cases, will be those individuals who meet the operational definition of a suspected case and have a confirmed diagnosis by molecular biology, according to the operational definition (conave).** 4. the time of acute respiratory symptoms should be no longer than 72h. 5. negative to the rapid test for influenza a/b. 6. live in an urban area with easy access for visits. - person of any age that has presented at least two of the following signs and symptoms: cough, fever or headache accompanied by at least one of the following signs or symptoms: dyspnea (signal of severity) arthralgia myalgia odynophagia / pharyngeal burning rhinorrhea conjunctivitis chest pain **sars-cov2 infection confirmed by molecular diagnostic by one laboratory from the national network of public health laboratories recognized by indre.